Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

153 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Transferrin receptor synthesis is an early event in B cell activation.
Futran J, Kemp JD, Field EH, Vora A, Ashman RF. Futran J, et al. J Immunol. 1989 Aug 1;143(3):787-92. J Immunol. 1989. PMID: 2473110
Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.
Kemp JD, Cardillo T, Stewart BC, Kehrberg E, Weiner G, Hedlund B, Naumann PW. Kemp JD, et al. Cancer Res. 1995 Sep 1;55(17):3817-24. Cancer Res. 1995. PMID: 7641199
Inhibition of lymphocyte activation with anti-transferrin receptor Mabs: a comparison of three reagents and further studies of their range of effects and mechanism of action.
Kemp JD, Thorson JA, Gomez F, Smith KM, Cowdery JS, Ballas ZK. Kemp JD, et al. Cell Immunol. 1989 Aug;122(1):218-30. doi: 10.1016/0008-8749(89)90162-7. Cell Immunol. 1989. PMID: 2526689
Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor.
Kemp JD, Smith KM, Kanner LJ, Gomez F, Thorson JA, Naumann PW. Kemp JD, et al. Blood. 1990 Sep 1;76(5):991-5. Blood. 1990. PMID: 2393721
Two mechanisms of transferrin receptor induction by anti-Ig in B cells.
Vora A, Stunz LL, Kemp JD, Ashman RF. Vora A, et al. J Immunol. 1990 Oct 1;145(7):2099-104. J Immunol. 1990. PMID: 2168917
Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity.
Kemp JD, Thorson JA, Stewart BC, Naumann PW. Kemp JD, et al. Cancer Res. 1992 Aug 1;52(15):4144-8. Cancer Res. 1992. PMID: 1638529
Kemp, K. M. Smith, L. J. Kanner, F. Gomez, J. A. Thorson, and P. W. Naumann, Blood, 76: 991-995, 1990). The current study is an attempt to analyze the mechanisms responsible for the synergistic interaction. ...
Kemp, K. M. Smith, L. J. Kanner, F. Gomez, J. A. Thorson, and P. W. Naumann, Blood, 76: 991-995, 1990). The current study is an attem
Effects of anti-transferrin receptor antibodies on the growth of neoplastic cells.
Kemp JD, Smith KM, Mayer JM, Gomez F, Thorson JA, Naumann PW. Kemp JD, et al. Pathobiology. 1992;60(1):27-32. doi: 10.1159/000163693. Pathobiology. 1992. PMID: 1543548 Review.
153 results
Jump to page
Feedback